M.D., CEO and Founder, Symbiome
Biography
Larry Weiss heads up a multi-disciplinary research and product development team at Weiss Bioscience, Inc. Based on a unique collaboration with an isolated tribe of Yanomami hunter-gatherers living a traditional lifestyle deep in the Amazon, Weiss Bioscience has sponsored three research expeditions and is translating the multi-omic findings into novel cosmetic and therapeutic interventions. The first of these, Symbiome branded skincare, launched in 2021, is formulated with proprietary rainforest-derived postbiotics that restore lost metabolic function. Prior to that, Weiss was Chief Medical Officer at AOBiome and Founder of CleanWell Company. He has 26 issued patents and 12 scientific publications. He is also the Founding Chair of The Global Microbiome Council.
Talk
Evolutionary Biology of the Skin Microbiome
• Metagenomics and metabolomics of the Yanomami skin microbiome
• Functional anatomy of the ancestral human skin microbiome
• Translating the ancestral skin microbiome into cosmetics and therapeutics
Session Abstract – PMWC 2022 Silicon Valley
Track Chair:
Rita Colwell, Johns Hopkins Bloomberg School of Public Health
Manoj Dadlani, CosmosID
Understanding mechanism of action and translating microbiome science into commercially viable therapeutics remains the biggest challenge in this emerging field. With that said, pharma and biotech across many different therapeutic indications and modalities are united in this global effort to bring novel microbiome-based therapies and diagnostics into the clinical domain. This session will include some of the most impactful and promising areas of the Microbiome field and panel discussions on the challenges for faster adoption.
-
Sessions:
- Intro and Overview to Microbiome
- Manoj Dadlani, CosmosID - Pharma Drug Development (PANEL)
Session Chair: Karim Dabbagh, Second Genome
- Jennifer Wortman, Seres Therapeutics
- Paul Garofolo, Locus Biosciences
- Rangaprasad Sarangarajan, Metabolon - AI in Microbiome
- Agnieszka Piotrowska, Ardigen
- Direct-To-Consumer Testing/Technologies (PANEL)
Session Chair: Nathan D. Price, Thorne HealthTech
- Kiran Krishnan, Microbiome Labs
- Nicole Scott, Cybele Microbiome
- Noosheen Hashemi, January AI - The Role of the Human Gut Microbiome on Various Diseases
- Colleen Cutcliffe, Pendulum Therapeutics
- Tor Savidge, Baylor College of Medicine
- Nikole Kimes, Siolta Therapeutics
- Susan Lynch, UCSF - The Gut/Brain Microbiome
- Mary Conrad, Axial Biotherapeutics
- Christopher Reyes, Bloom Science
- Evolutionary Biology of the Skin Microbiome
- Larry Weiss, Symbiome - Showcase
- Heloise Breton, DNA Genotek
- Nathan Price, Thorne HealthTech
- Mo Langhi, CosmosID
- Rangaprasad Sarangarajan, Metabolon
